脉管瘤栓在早期宫颈鳞癌中的意义
摘要
宫颈癌是女性最常见的恶性肿瘤之一,淋巴结转移、宫旁受侵和切缘不净被公认为是宫颈癌的不良预后因素,而脉管瘤栓(LVSI)、肿瘤分化等临床病理参数在宫颈癌临床中的意义目前存有争议。
出处
《中华全科医师杂志》
2009年第10期724-726,共3页
Chinese Journal of General Practitioners
参考文献20
-
1孔为民,李风霜,王彤,王雁,刘婷婷.宫颈癌术后放射治疗97例分析[J].中国实用妇科与产科杂志,2006,22(8):591-593. 被引量:4
-
2俞华.143例子宫颈癌术后复发原因分析[J].中国肿瘤临床,2003,30(1):34-36. 被引量:9
-
3Yamaguchi H, Ueda M, Kanemura M, et al. Clinical efficacy of conservative laser therapy for early-stage cervical cancer. Int J Gynecol Cancer ,2007, 17: 455-459.
-
4Itsukaichi M, Kurata H, Matsushita M, et al. Stage Ial cervical squamous cell carcinoma: conservative management after laser conization with positive margins. Gynecol Oncol, 2003, 90 : 387- 389.
-
5Lee KB, Lee JM, Park CY, et al. Lymph node metastasis and lymph vascular space invasion in microinvasive squamous cell carcinoma of the uterine cervix. Int J Gynecol Cancer,2006, 16: 1184-1187.
-
6Buckley SL, Tritz DM, Van Le L, et al. Lymph node metastases and prognosis in patients with stage IA2 cervical cancer. Gynecol Oncol , 1996 ,63 : 4-9.
-
7Elliott P, Coppleson M, Russell P, et al. Early invasive ( FIGO stage IA) carcinoma of the cervix: a clinico-pathalogic study of 476 cases. Int J Gynecol Cancer, 2000, 10: 42-52.
-
8Kim SM, Choi HS, Byun JS. Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. lnt J Gynecol Cancer ,2000 , 10: 305-312.
-
9Silva-Filho AL, Reis FM, Traiman P, et al. Clinicopathological features influencing pelvic lymph node metastasis and vaginal and parametrial involvement in patients with carcinoma of the cervix. Gynecol Obstet Invest, 2005 , 59: 92-96.
-
10Wright JD, Grigsby PW, Brooks R, et al. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy. Cancer, 2007 , 110: 1281-1286.
二级参考文献21
-
1[1]Samlal RK, Velden JVD, Kate FWT, et al. Surgical pathologic factors that predict recurrence in stage Ⅰ B and Ⅱ A cervical carcinoma patients with negative pelvic lymph nodes[J]. Cancer, 1997,80(7): 1234~1240
-
2[2]Sedlis A, Bundy B, Rotman M, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage Ⅰ B carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study[J]. Gynecol Oncol, 1999,73:177~183
-
3[3]Kamura T, Tsukamoto N, Tsuruchi N, et al. Multivariate analysis of the histopatholigic prognosuc factors of cervical cancer in patients undergoing radical hysterecotomy[J]. Cancer,1992, 69(1): 181~186
-
4[4]Schorge J, Molpus K, Koelliker D, et al. Stage Ⅰ B and Ⅱ A cervical cancer with negative Lymphnodes: The role of adjuvantradiotherapy after radical hysterectomy [J]. Gynecol Oncol,1997, 66:31~35
-
5[5]Sevin BU, Nadji M, Lampo B, et al. Prognostic factors of early stage cervical carcer treated by radical hysterectomy [J].Cancer Supplement, 1995, 76 (10): 1978~1986
-
6[6]Bloss JD, Bennan ML, Mukhererjee J. Bulky stage Ⅰ B cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy[J]. Gynecol Oncol, 1992,47:21~27
-
7[7]Perez CA, Grigsby PW, Camel HM, et al. Irradiation alone or combined with surgery in stage Ⅰ B Ⅱ A and Ⅱ B carcinoma of uterine cervix: update of a nonrandomized comparison [J].Int J Radiat Oncol Biol Phys, 1995, 31:1007~1008
-
8[8]Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix [J]. J Clin Oncol,2000, 18 8): 1606~1613
-
9Nelson JH Jr.Clinical invasive carcinoma of cervix:place of radical hysterectomy as primary treatment[M]// Coppleson M,ed.Gynecologic oncology.Melbourne:Churchill Livingstone,1992:697.
-
10Larson DM.Stage Ib cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy:role of adjuvant radiotherapy[J].Obstet Gynecol,1987,69:378-381.
共引文献11
-
1温翠侠,刘凌,管峦.子宫颈癌根治术后同步放化疗与放疗序贯化疗及单纯放疗临床对比研究[J].中华肿瘤防治杂志,2010,17(11):854-856. 被引量:12
-
2叶元,尹茳平,李力,王芙霞,王一兵,唐柳林,李昱川.宫颈癌手术治疗后复发临床病理因素的循证评价[J].广西医科大学学报,2011,28(4):577-579. 被引量:2
-
3李魁秀,刘红,房朝晖,牛书怀,宋藏珠,樊晓妹.子宫颈癌患者180例术后放疗的临床观察[J].河北医科大学学报,2011,32(10):1140-1142. 被引量:2
-
4汪丹.子宫颈癌根治术后不同放疗措施的临床疗效对比研究[J].按摩与康复医学,2012,3(20):22-22. 被引量:1
-
5朱红荣,马德花,鲁强,赵淑萍.宫颈癌远处转移37例临床分析[J].中华肿瘤防治杂志,2013,20(19):1522-1524. 被引量:15
-
6黄喜锋.PP放疗增敏放化疗同步与放化疗序贯治疗复发耐药肿瘤疗效的比较分析[J].中国医药指南,2014,12(27):56-57.
-
7苏小岩,胡艳,张文涛,胡科,蔡志强,王茜.宫颈癌术后不同放疗方式对疗效及周围组织影响的对比研究[J].长江大学学报(自科版)(下旬),2015,12(6):26-27. 被引量:4
-
8金志红.宫颈癌术后复发的临床因素相关性分析[J].当代医学,2016,22(15):26-27. 被引量:6
-
9唐静.97例宫颈癌根治术后并发症分析及预防[J].中国实用医药,2016,11(23):76-77. 被引量:4
-
10孙凌飞,温翠侠,刘凌.子宫颈癌根治术后同步与序贯放化疗的临床研究[J].现代中西医结合杂志,2016,25(36):4071-4072. 被引量:4
-
1邓新,刘岿然,王佳斌.早期宫颈鳞癌癌周组织及盆腔淋巴结中podoplanin及高危型HPV的检测及意义[J].现代肿瘤医学,2013,21(9):2073-2075. 被引量:1
-
2邓秀文,邹文.E-cadherin和Vimentin表达与早期宫颈癌临床病理特征及预后的关系[J].临床肿瘤学杂志,2016,21(2):160-165. 被引量:28
-
3武宝平,张秀珍.剖宫产同时实施子宫肌瘤剔除术68例临床分析[J].山东医药,2006,46(24):72-73. 被引量:6
-
4林丹霞,陈晨,陈世坚,丘希辉,方玫玫.三维适形放疗联合DF方案化疗治疗局部晚期食管癌临床观察[J].现代肿瘤医学,2014,22(6):1332-1334. 被引量:6
-
5梁香存,梁凯,王庆,才虹美,梁健,张俊萍.小细胞肺癌脑转移发生的时间对生存的影响[J].实用医学杂志,2015,31(17):2866-2867. 被引量:2
-
6徐汉平,谢兴旺,王光新,石益龄.原发性小肠恶性肿瘤临床误诊分析[J].临床外科杂志,2001,9(1):31-32. 被引量:3
-
7刘健,李学瑞.化疗联合贝伐单抗在HER2阴性转移性乳腺癌一线治疗的研究[J].循证医学,2012,12(3):150-152. 被引量:1
-
8曲雁红.吉非替尼治疗晚期非小细胞肺癌的疗效观察[J].中国现代药物应用,2013,7(7). 被引量:2
-
9高鹏,凡杰,夏术阶.射频消融和冷冻消融在治疗小肾癌中的应用[J].国外医学(泌尿系统分册),2005,25(1):16-19. 被引量:1
-
10石磊,陈平,何春兰,赵伟.分化型甲状腺癌初次手术方式的探讨(附103例分析)[J].实用临床医药杂志,2008,12(7):52-53. 被引量:4